Thermo Fisher announces the recent launch of the TrueMark Infectious Disease Research Panels, which are designed to enable rapid and accurate detection and categorization for investigating microorganisms that cause respiratory, vaginal, urinary, gastrointestinal, and sexually transmitted diseases. These real-time PCR syndromic panels are analytically sensitive enough to enable the analysis of a wide range of infectious disease pathogens. Leveraging real-time PCR technology, the predefined and customizable panel options allow the user to choose from more than 90 different bacterial and viral strain assays to generate results within 4 hours from taking the samples.

• Thermo Fisher Scientific
  For more information, visit medlabmag.com/info